Vaccine development begins at the bench. Whether your vaccine program requires the expression and purification of proteins, virus-like-particles, RNA, recombinant viral vectors, or live-attenuated pathogens (viruses/bacteria), Paragon will help you with your research and pre-clinical vaccine studies. As the project advances, we will also provide GMP manufacturing services to bring your vaccine candidate through Phase I/II Clinical Trials. Specific experience to date include:

VLP Candidate Vaccines (Transient Mammalian and BEVS Expression)

HPV, HIV, Ebola Zaire Virus, Ebola Sudan Virus, Marburg Virus, CMV

Antigen Candidate Vaccines (including Polysaccharide Conjugated Vaccines)

Salmonella, S. pneumoniae, Cholera, Chlamydia, Anthrax, HSV

Alphavirus Replicon Particles (Ebola – Zaire, Sudan and Marburg Virus)

Live-attenuated Virus & Bacterial Vaccines

Chlamydia, RSV, CMV, Oncolytic viruses, Shigella, S. pneumoniae, C. diphtheriae

Have questions? Ready to get started?

Fill out the form below and we’ll be in touch ASAP.

* These fields are required.

Who we are. How we work.

Get more info on specific expertise and capabilities.

Have a question? Let us help.